82 related articles for article (PubMed ID: 15523694)
1. Genotype phenotype correlations in Israeli colorectal cancer patients.
Starinsky S; Figer A; Ben-Asher E; Geva R; Flex D; Fidder HH; Zidan J; Lancet D; Friedman E
Int J Cancer; 2005 Mar; 114(1):58-73. PubMed ID: 15523694
[TBL] [Abstract][Full Text] [Related]
2. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
Fidder HH; Figer A; Geva R; Flex D; Schayek H; Avidan B; Meir SB; Friedman E
Am J Gastroenterol; 2005 Jun; 100(6):1376-80. PubMed ID: 15929773
[TBL] [Abstract][Full Text] [Related]
3. The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews.
Boursi B; Sella T; Liberman E; Shapira S; David M; Kazanov D; Arber N; Kraus S
Eur J Cancer; 2013 Nov; 49(17):3680-5. PubMed ID: 23896379
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer.
Figer A; Irmin L; Geva R; Flex D; Sulkes A; Friedman E
Br J Cancer; 2001 Aug; 85(4):523-6. PubMed ID: 11506490
[TBL] [Abstract][Full Text] [Related]
5. Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study.
Drucker L; Stackievitz R; Shpitz B; Yarkoni S
Anticancer Res; 2000; 20(1B):559-61. PubMed ID: 10769725
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analyses of colon cancer in I1307K APC mutation carriers compared with noncarriers.
Fidder HH; Barshack I; Chen-Shtoyerman R; Onaca N; Goldberg I; Rath P; Theodor L; Bar-Meir S; Friedman E
Dig Dis Sci; 2003 Jun; 48(6):1102-5. PubMed ID: 12822869
[TBL] [Abstract][Full Text] [Related]
7. Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype.
Drucker L; Shpilberg O; Neumann A; Shapira J; Stackievicz R; Beyth Y; Yarkoni S
Cancer; 2000 Feb; 88(4):755-60. PubMed ID: 10679643
[TBL] [Abstract][Full Text] [Related]
8. The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features.
Locker GY; Kaul K; Weinberg DS; Gatalica Z; Gong G; Peterman A; Lynch J; Klatzco L; Olopade OI; Bomzer CA; Newlin A; Keenan E; Tajuddin M; Knezetic J; Coronel S; Lynch HT
Cancer Genet Cytogenet; 2006 Aug; 169(1):33-8. PubMed ID: 16875934
[TBL] [Abstract][Full Text] [Related]
9. The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews.
Strul H; Barenboim E; Leshno M; Gartner M; Kariv R; Aljadeff E; Aljadeff Y; Kazanov D; Strier L; Keidar A; Knaani Y; Degani Y; Alon-Baron L; Sobol-Dvory H; Halpern Z; Arber N
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1012-5. PubMed ID: 14578136
[TBL] [Abstract][Full Text] [Related]
10. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
11. Genetic factors and colorectal cancer in Ashkenazi Jews.
Locker GY; Lynch HT
Fam Cancer; 2004; 3(3-4):215-21. PubMed ID: 15516844
[TBL] [Abstract][Full Text] [Related]
12. Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53.
Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Int J Cancer; 2006 May; 118(10):2479-84. PubMed ID: 16353134
[TBL] [Abstract][Full Text] [Related]
13. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
[TBL] [Abstract][Full Text] [Related]
14. MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer.
Hubner RA; Lubbe S; Chandler I; Houlston RS
Hum Mol Genet; 2007 May; 16(9):1072-7. PubMed ID: 17350979
[TBL] [Abstract][Full Text] [Related]
15. The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel.
Figer A; Irmin L; Geva R; Flex D; Sulkes J; Sulkes A; Friedman E
Br J Cancer; 2001 Feb; 84(4):478-81. PubMed ID: 11207041
[TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival.
Lu S; Pardini B; Cheng B; Naccarati A; Huhn S; Vymetalkova V; Vodickova L; Buchler T; Hemminki K; Vodicka P; Försti A
PLoS One; 2014; 9(10):e111061. PubMed ID: 25350395
[TBL] [Abstract][Full Text] [Related]
17. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
Wang AZ; Zhu ZZ; Cong WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants in C-type lectin genes are associated with colorectal cancer susceptibility and clinical outcome.
Lu S; Bevier M; Huhn S; Sainz J; Lascorz J; Pardini B; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
Int J Cancer; 2013 Nov; 133(10):2325-33. PubMed ID: 23650115
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases.
Figer A; Shtoyerman-Chen R; Tamir A; Geva R; Irmin L; Flex D; Theodor L; Sulkes A; Sadetzki S; Bar-Meir S; Friedman E
Br J Cancer; 2001 Nov; 85(9):1368-71. PubMed ID: 11720476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
